Clinical laboratory parameters

Biomarker

1 paper1 finding

  • Human trial1

Interventions

1

Spermidine

no changein humans1

1 study
  1. Spermidine has no effect on clinical laboratory parameters in humans.

    “40 mg/day hpSPD did not result in any significant changes in clinical, lipids, chemistry, or hematological parameters compared to placebo.”

    Human trialtrihydrochloride supplement (hpSPD)40 mg/dayup to 28 daysmalesn = 37

    Supplementation of spermidine at 40 mg/day has minimal effects on circulating polyamines: An exploratory double-blind randomized controlled trial in older men

    Nutrition research (New York, N.Y.)Sep 19, 2024

More on Spermidine

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 1Oct 2026: 02 in 12 months